Reaction
Retinal Degeneration reporting signals
As of the last recalculation, Retinal Degeneration appears in 1,239 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 62.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 92 | 62.8 | 63.0 |
| Faricimab | 20 | 42.1 | 42.2 |
| Aflibercept | 70 | 39.9 | 40.0 |
| Melphalan Hydrochloride | 31 | 21.3 | 21.3 |
| Atropine | 10 | 20.4 | 20.5 |
| Vigabatrin | 15 | 17.5 | 17.5 |
| Ganciclovir | 10 | 16.5 | 16.6 |
| Melphalan | 22 | 16.5 | 16.5 |
| Ganciclovir Sodium | 10 | 16.0 | 16.0 |
| Atropine Sulfate | 10 | 15.7 | 15.7 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 17 | 12.4 | 12.4 |
| Hydroxychloroquine | 50 | 11.7 | 11.7 |
| Asfotase Alfa | 6 | 10.1 | 10.1 |
| Brinzolamide | 5 | 9.7 | 9.7 |
| Triamcinolone Acetonide | 17 | 9.4 | 9.4 |
| Bevacizumab | 61 | 8.7 | 8.7 |
| Brimonidine Tartrate | 9 | 8.5 | 8.5 |
| Timolol | 6 | 8.4 | 8.4 |
| Deferasirox | 11 | 7.0 | 7.0 |